CVS Caremark will cover Lilly’s weight loss drug Zepbound once again
CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly said Thursday. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. CVS Caremark is one of the country’s largest pharmacy benefit managers, … Read more